Autoimmune Pancreatitis

Sajan Jiv Singh Nagpal, Ayush Sharma, Suresh T Chari

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Over the course of the last 2 decades our knowledge of autoimmune pancreatitis has increased exponentially. In this review, we summarize the clinical presentation, diagnosis and treatment of AIP, to better allow general gastroenterologists and primary care providers to consider AIP as a as a rare but important cause of painless obstructive jaundice and recurrent acute pancreatitis. While steroids remain the mainstay of first line therapy, a number of patients with type 1 AIP require immunomodulators or rituximab to maintain remission; recommendations on the management of relapses continue to evolve.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalAmerican Journal of Gastroenterology
DOIs
StateAccepted/In press - Jun 18 2018

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Autoimmune Pancreatitis'. Together they form a unique fingerprint.

  • Cite this

    Nagpal, S. J. S., Sharma, A., & Chari, S. T. (Accepted/In press). Autoimmune Pancreatitis. American Journal of Gastroenterology, 1-9. https://doi.org/10.1038/s41395-018-0146-0